Literature DB >> 21890629

Extra-long Gαs variant XLαs protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling.

Zun Liu1, Serap Turan, Vanessa L Wehbi, Jean-Pierre Vilardaga, Murat Bastepe.   

Abstract

Murine models indicate that Gαs and its extra-long variant XLαs, both of which are derived from GNAS, markedly differ regarding their cellular actions, but these differences are unknown. Here we investigated activation-induced trafficking of Gαs and XLαs, using immunofluorescence microscopy, cell fractionation, and total internal reflection fluorescence microscopy. In transfected cells, XLαs remained localized to the plasma membrane, whereas Gαs redistributed to the cytosol after activation by GTPase-inhibiting mutations, cholera toxin treatment, or G protein-coupled receptor agonists (isoproterenol or parathyroid hormone (PTH)(1-34)). Cholera toxin treatment or agonist (isoproterenol or pituitary adenylate cyclase activating peptide-27) stimulation of PC12 cells expressing Gαs and XLαs endogenously led to an increased abundance of Gαs, but not XLαs, in the soluble fraction. Mutational analyses revealed two conserved cysteines and the highly charged domain as being critically involved in the plasma membrane anchoring of XLαs. The cAMP response induced by M-PTH(1-14), a parathyroid hormone analog, terminated quickly in HEK293 cells stably expressing the type 1 PTH/PTH-related peptide receptor, whereas the response remained maximal for at least 6 min in cells that co-expressed the PTH receptor and XLαs. Although isoproterenol-induced cAMP response was not prolonged by XLαs expression, a GTPase-deficient XLαs mutant found in certain tumors and patients with fibrous dysplasia of bone and McCune-Albright syndrome generated more basal cAMP accumulation in HEK293 cells and caused more severe impairment of osteoblastic differentiation of MC3T3-E1 cells than the cognate Gαs mutant (gsp oncogene). Thus, activated XLαs and Gαs traffic differently, and this may form the basis for the differences in their cellular actions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21890629      PMCID: PMC3207409          DOI: 10.1074/jbc.M111.240150

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  Igf2 imprinting in development and disease.

Authors:  W Reik; M Constancia; W Dean; K Davies; L Bowden; A Murrell; R Feil; J Walter; G Kelsey
Journal:  Int J Dev Biol       Date:  2000       Impact factor: 2.203

2.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

3.  Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization.

Authors:  H A Pasolli; M Klemke; R H Kehlenbach; Y Wang; W B Huttner
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Coupling of beta2-adrenoceptors to XLalphas and Galphas: a new insight into ligand-induced G protein activation.

Authors:  A I Kaya; O Ugur; S S Oner; M Bastepe; H O Onaran
Journal:  J Pharmacol Exp Ther       Date:  2009-01-14       Impact factor: 4.030

5.  A proline-rich region and nearby cysteine residues target XLalphas to the Golgi complex region.

Authors:  O Ugur; T L Jones
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

6.  Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism.

Authors:  S Yu; O Gavrilova; H Chen; R Lee; J Liu; K Pacak; A F Parlow; M J Quon; M L Reitman; L S Weinstein
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

7.  Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.

Authors:  Virginie Mariot; Joy Y Wu; Cumhur Aydin; Giovanna Mantovani; Matthew J Mahon; Agnès Linglart; Murat Bastepe
Journal:  Bone       Date:  2010-09-29       Impact factor: 4.398

8.  Transgenic overexpression of the extra-large Gsα variant XLαs enhances Gsα-mediated responses in the mouse renal proximal tubule in vivo.

Authors:  Zun Liu; Hiroko Segawa; Cumhur Aydin; Monica Reyes; Reinhold G Erben; Lee S Weinstein; Min Chen; Vladimir Marshansky; Leopold F Fröhlich; Murat Bastepe
Journal:  Endocrinology       Date:  2011-02-08       Impact factor: 4.736

9.  Diverse somatic mutation patterns and pathway alterations in human cancers.

Authors:  Zhengyan Kan; Bijay S Jaiswal; Jeremy Stinson; Vasantharajan Janakiraman; Deepali Bhatt; Howard M Stern; Peng Yue; Peter M Haverty; Richard Bourgon; Jianbiao Zheng; Martin Moorhead; Subhra Chaudhuri; Lynn P Tomsho; Brock A Peters; Kanan Pujara; Shaun Cordes; David P Davis; Victoria E H Carlton; Wenlin Yuan; Li Li; Weiru Wang; Charles Eigenbrot; Joshua S Kaminker; David A Eberhard; Paul Waring; Stephan C Schuster; Zora Modrusan; Zemin Zhang; David Stokoe; Frederic J de Sauvage; Malek Faham; Somasekar Seshagiri
Journal:  Nature       Date:  2010-07-28       Impact factor: 49.962

10.  Retromer terminates the generation of cAMP by internalized PTH receptors.

Authors:  Timothy N Feinstein; Vanessa L Wehbi; Juan A Ardura; David S Wheeler; Sebastien Ferrandon; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

View more
  11 in total

1.  A G protein-coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23.

Authors:  Qing He; Lauren T Shumate; Julia Matthias; Cumhur Aydin; Marc N Wein; Jordan M Spatz; Regina Goetz; Moosa Mohammadi; Antonius Plagge; Paola Divieti Pajevic; Murat Bastepe
Journal:  JCI Insight       Date:  2019-09-05

Review 2.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 3.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

4.  Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.

Authors:  Nicolas Richard; Arnaud Molin; Nadia Coudray; Pauline Rault-Guillaume; Harald Jüppner; Marie-Laure Kottler
Journal:  J Clin Endocrinol Metab       Date:  2013-07-24       Impact factor: 5.958

Review 5.  The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene.

Authors:  Serap Turan; Murat Bastepe
Journal:  Horm Res Paediatr       Date:  2013-10-03       Impact factor: 2.852

6.  Large G protein α-subunit XLαs limits clathrin-mediated endocytosis and regulates tissue iron levels in vivo.

Authors:  Qing He; Richard Bouley; Zun Liu; Marc N Wein; Yan Zhu; Jordan M Spatz; Chia-Yu Wang; Paola Divieti Pajevic; Antonius Plagge; Jodie L Babitt; Murat Bastepe
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

7.  Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth.

Authors:  Anara Karaca; Vijayram Reddy Malladi; Yan Zhu; Olta Tafaj; Elena Paltrinieri; Joy Y Wu; Qing He; Murat Bastepe
Journal:  Bone       Date:  2018-02-20       Impact factor: 4.398

8.  Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction.

Authors:  Benedetta Izzi; Inge Francois; Veerle Labarque; Chantal Thys; Christine Wittevrongel; Koen Devriendt; Eric Legius; Annick Van den Bruel; Marc D'Hooghe; Diether Lambrechts; Francis de Zegher; Chris Van Geet; Kathleen Freson
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

9.  The G protein α subunit variant XLαs promotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo.

Authors:  Qing He; Yan Zhu; Braden A Corbin; Antonius Plagge; Murat Bastepe
Journal:  Sci Signal       Date:  2015-08-25       Impact factor: 8.192

10.  An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer.

Authors:  I Garcia-Murillas; R Sharpe; A Pearson; J Campbell; R Natrajan; A Ashworth; N C Turner
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.